Identification of transcription factors associated with castration-resistance: Is the serum responsive factor a potential therapeutic target?-Reference-Cited by-同舟云学术

Identification of transcription factors associated with castration-resistance: Is the serum responsive factor a potential therapeutic target?

Published:2013-01-28 Issue:7 Volume:73 Page:743-753
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Prencipe Maria,Madden Stephen F.,O'Neill Amanda,O'Hurley Gillian,Culhane Aedin,O'Connor Darran,Klocker Helmut,Kay Elaine W.,Gallagher William M.,Watson William R.

Funder

Science Foundation Ireland Strategic Research Cluster

Molecular Therapeutics for Cancer Ireland

FP7 Marie Curie Industry-Academia Partnership and Pathways Program

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.22618/fullpdf

Reference43 articles.

1. Mechanisms underlying the development of androgen-independent prostate cancer;Pienta;Clin Cancer Res,2006

2. Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth;Montgomery;Cancer Res,2008

3. Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation;Gill;Mol Cancer,2009

4. EORTC Genitourinary Tract Cancer Group Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): An EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer;Sternberg;Ann Oncol,2009

5. Molecular alterations in primary prostate cancer after androgen ablation therapy;Best;Clin Cancer Res,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SRF inhibitors reduce prostate cancer cell proliferation through cell cycle arrest in an isogenic model of castrate-resistant prostate cancer;Cell Cycle;2023-06-28

2. Emerging role for the Serum Response Factor (SRF) as a potential therapeutic target in cancer;Expert Opinion on Therapeutic Targets;2022-02-01

3. Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis;Prostate Cancer and Prostatic Diseases;2021-08-21

4. Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer;Cancers;2020-11-27

5. Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy;Oncogene;2019-02-11